Milestone
Portfolio company Apnimed's shares jumped after an upsized US IPO.
Apnimed
JUL 31, 2026
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Apnimed
AdvanCell
Ramp
Transcend Therapeutics
Cognition
Cerebras
Anthropic